CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Johnson & Johnson  (JNJ)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 



 

Johnson & Johnson

JNJ's Financial Statements and Analysis




Johnson & Johnson reported in I. Quarter net earnings per share of $1.61 an increase by 0 % year on year from $1.54 and an improvement of 0 % from $1.43 realized in IV. Quarter (Jan 01 2017).

Johnson & Johnson's Revenue rose by % in I. Quarter (Apr 02 2017) year on year, to $17,766 million and declined by -1.88 % sequentially.


Johnson & Johnson is
More on JNJ's Income Statement

I. Quarter
Earnings Per Share Revenues
$ 1.61 $  17,766 Mill
$+0.07     +4.55 % $+284M     +1.62 %
You need to upgrade your Flash Player


       
  • PROCRIT 77.52% Y/Y,
• RISPERDAL 76.41% Y/Y,
• REMICADE 83.39% Y/Y,
• VELCADE 75.58% Y/Y,
• CONCERTA 218.52% Y/Y,
• INVEGA 105.77% Y/Y
   
     
       
  • Other -2.12% Y/Y,
• Total Pharmaceutical -4.35% Y/Y,
• Med. Dev. & Diag. -3.24% Y/Y,
• Nutritionals -4.42% Y/Y,
• Skin Care -2.83% Y/Y,
• Total Consumer -2.95% Y/Y
   
     


JNJ's Segments

JNJ's NET INCOME

Johnson & Johnson's net income of $4,422 million in I. Quarter increased by 3.03 % from net earnings of $4,292 million achieved in I. Quarter a year ago.

Sequentially net earnings grew by 11.13 % from net income of $3,979.00 million realized in previous quarter.

More on JNJ's Growth



Johnson & Johnson Income Growth by Division
• Total Pharmaceutical 39.91% Y/Y,
• Total Consumer 232.92% Y/Y • Med. Dev. & Diag. -11.36% Y/Y Inventories Inventories grew by 8.67 % to $8,878 million from I. Quarter a year ago, sequentially inventories rose by 9.01 %. JNJ's Cash flow In I. Quarter company's net cash flow was $1,937 million, capital expenditures grew by -12.36%, to $-560 millions compare to same quarter a year ago and rose by -48.76% from IV. Quarter (Jan 01 2017).

More on JNJ's Cash flow Statement



Johnson & Johnson payed out dividend of $3.20 per share in last 52 weeks representing 53.33 % of net earning per share in trailing twelve-month period.

During the same period Johnson & Johnson earned $ 7.00 cash per share, on a free-cash flow basis 116.6 % of net earning per share.

Book value grew by 0.84 % sequentially to $25.54 per share, -7.52% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ 5.82 per share from $ 7.46.

Company repurchased 26.10 million shares or 0.94 % in I. Quarter.
Interest Coverage Ratio was 27.08. Debt Coverage Ratio was 0.74.

More on JNJ's Dividends
 Market Capitalization (Millions) 375,796
 Shares Outstanding (Millions) 2,755
 Total Debt (Millions $) 32,370
 Revenue (TTM) (Millions $) 72,174
 Net Income (TTM) (Millions $) 16,670
 Cash Flow (TTM) (Millions $) 7,048
 Capital Exp. (TTM) (Millions $) -3,147
 Dividend TTM ($) 3.2 $
 Dividend Yield TTM (%) 2.35 %
 Employees (TTM) $ 126,500


   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com